736 related articles for article (PubMed ID: 23355776)
1. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
[TBL] [Abstract][Full Text] [Related]
2. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
[TBL] [Abstract][Full Text] [Related]
3. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery.
Wu X; Zhang W; Hayes D; Mansour HM
Int J Nanomedicine; 2013; 8():1269-83. PubMed ID: 23569375
[TBL] [Abstract][Full Text] [Related]
5. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
Wu X; Hayes D; Zwischenberger JB; Kuhn RJ; Mansour HM
Drug Des Devel Ther; 2013; 7():59-72. PubMed ID: 23403805
[TBL] [Abstract][Full Text] [Related]
6. High-performing dry powder inhalers of paclitaxel DPPC/DPPG lung surfactant-mimic multifunctional particles in lung cancer: physicochemical characterization, in vitro aerosol dispersion, and cellular studies.
Meenach SA; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
AAPS PharmSciTech; 2014 Dec; 15(6):1574-87. PubMed ID: 25139763
[TBL] [Abstract][Full Text] [Related]
7. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
[TBL] [Abstract][Full Text] [Related]
8. Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery.
Duan J; Vogt FG; Li X; Hayes D; Mansour HM
Int J Nanomedicine; 2013; 8():3489-505. PubMed ID: 24092972
[TBL] [Abstract][Full Text] [Related]
9. Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery.
Gomez AI; Acosta MF; Muralidharan P; Yuan JX; Black SM; Hayes D; Mansour HM
Pulm Pharmacol Ther; 2020 Oct; 64():101975. PubMed ID: 33137515
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.
Li X; Mansour HM
AAPS PharmSciTech; 2011 Dec; 12(4):1420-30. PubMed ID: 22038473
[TBL] [Abstract][Full Text] [Related]
12. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
13. Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization,
Acosta MF; Muralidharan P; Grijalva CL; Abrahamson MD; Hayes D; Fineman JR; Black SM; Mansour HM
Ther Adv Respir Dis; 2021; 15():1753466621998245. PubMed ID: 33719747
[TBL] [Abstract][Full Text] [Related]
14. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
Eedara BB; Tucker IG; Das SC
Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294
[TBL] [Abstract][Full Text] [Related]
15. Preparation and physicochemical characterization of spray-dried and jet-milled microparticles containing bosentan hydrate for dry powder inhalation aerosols.
Lee HJ; Kang JH; Lee HG; Kim DW; Rhee YS; Kim JY; Park ES; Park CW
Drug Des Devel Ther; 2016; 10():4017-4030. PubMed ID: 28008226
[TBL] [Abstract][Full Text] [Related]
16. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
Lu W; Rades T; Rantanen J; Yang M
Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
[TBL] [Abstract][Full Text] [Related]
17. Design and development of innovative microparticulate/nanoparticulate inhalable dry powders of a novel synthetic trifluorinated chalcone derivative and Nrf2 agonist.
Muralidharan P; Jones B; Allaway G; Biswal SS; Mansour HM
Sci Rep; 2020 Nov; 10(1):19771. PubMed ID: 33188247
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
Pinto JT; Zellnitz S; Guidi T; Roblegg E; Paudel A
Mol Pharm; 2018 Jul; 15(7):2827-2839. PubMed ID: 29856921
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system.
Alhajj N; O'Reilly NJ; Cathcart H
Int J Pharm; 2022 Apr; 618():121657. PubMed ID: 35288220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
